Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Outcomes of patients with Hodgkin lymphoma receiving Brentuximab Vedotin (BV) as maintenance therapy after ASCT according to previous exposure to BV. A retrospective analysis of the EBMT Lymphoma Working Party in collaboration with GELTAMO, FIL, LYSA, and Turkish Lymphoma Group

Title:	Outcomes of patients with Hodgkin lymphoma receiving Brentuximab Vedotin (BV) as maintenance therapy after ASCT according to previous exposure to BV. A retrospective analysis of the EBMT Lymphoma Working Party in collaboration with GELTAMO, FIL, LYSA, and Turkish Lymphoma Group
Authors:	Martínez, Carmen^{Aff1, IDs41409025025684_cor1}; Khvedelidze, Irma^Aff2; Fekom, Mathilde^Aff2; Deau Fischer, Benedicte^{Aff3, Aff4}; Marouf, Amira^Aff5; Ghesquières, Hervé^Aff6; Fornecker, Luc-Mathieu^Aff7; Merli, Francesco^Aff8; Stefani, Piero Maria^Aff9; Massaro, Fulvio^Aff10; Botto, Barbara^Aff11; Ferhanoğlu, Burhan^Aff12; Akay, Olga Meltem^Aff13; Özbalak, Murat^Aff14; Espeso de Haro, Manuel^Aff15; Romero, Samuel^Aff16; Galimard, Jaques-Emmanuel^Aff2; Glass, Bertram^Aff17; Bazarbachi, Ali^Aff18; Sureda, Anna^Aff19
Source:	Bone Marrow Transplantation: Official journal of the European Society for Blood and Marrow Transplantation. 60(6):879-887
Database:	Springer Nature Journals